Temat: "B-Cell" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Dynamic hydrogen peroxide levels reveal a rate-dependent sensitivity in B-cell lymphoma signaling.
Autorzy:: Witmond M; Institute for Molecules and Materials (IMM), Radboud University Nijmegen, Nijmegen, The Netherlands.
Keizer E; Institute for Molecules and Materials (IMM), Radboud University Nijmegen, Nijmegen, The Netherlands.
Kiffen B; Institute for Molecules and Materials (IMM), Radboud University Nijmegen, Nijmegen, The Netherlands.
Huck WTS; Institute for Molecules and Materials (IMM), Radboud University Nijmegen, Nijmegen, The Netherlands. .
van Buggenum JAGL; Institute for Molecules and Materials (IMM), Radboud University Nijmegen, Nijmegen, The Netherlands. .; Single Cell Discoveries (SCD), Utrecht, The Netherlands. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 21; Vol. 14 (1), pp. 4265. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:: Journal Article
MeSH Terms:: Hydrogen Peroxide*
Lymphoma, Large B-Cell, Diffuse*/pathology
Humans ; Signal Transduction ; Phosphorylation ; Receptors, Antigen, B-Cell/metabolism ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome.
Autorzy:: Wagner A; Centre Hospitalier Universitaire de Québec Research Center-Université Laval (CRCHUQc-UL), Faculty of Pharmacy, and Centre de Recherche sur le Cancer de l'Université Laval (CRC-UL), Université Laval, Québec, QC G1V 4G2, Canada.
Rouleau M; Centre Hospitalier Universitaire de Québec Research Center-Université Laval (CRCHUQc-UL), Faculty of Pharmacy, and Centre de Recherche sur le Cancer de l'Université Laval (CRC-UL), Université Laval, Québec, QC G1V 4G2, Canada.
Villeneuve L; Centre Hospitalier Universitaire de Québec Research Center-Université Laval (CRCHUQc-UL), Faculty of Pharmacy, and Centre de Recherche sur le Cancer de l'Université Laval (CRC-UL), Université Laval, Québec, QC G1V 4G2, Canada.
Le T; Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, 1090 Vienna, Austria.
Peltier C; Department of Internal Medicine & Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P4, Canada.; CancerCare Manitoba Research Institute, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada.
Allain ÉP; Molecular Genetics Laboratory, Dr. Georges-L-Dumont University Hospital Center, Moncton, NB E1C 2Z3, Canada.
Beaudoin C; Centre Hospitalier Universitaire de Québec Research Center-Université Laval (CRCHUQc-UL), Faculty of Pharmacy, and Centre de Recherche sur le Cancer de l'Université Laval (CRC-UL), Université Laval, Québec, QC G1V 4G2, Canada.
Tremblay S; Centre Hospitalier Universitaire de Québec Research Center-Université Laval (CRCHUQc-UL), Faculty of Pharmacy, and Centre de Recherche sur le Cancer de l'Université Laval (CRC-UL), Université Laval, Québec, QC G1V 4G2, Canada.
Courtier F; Centre Hospitalier Universitaire de Québec Research Center-Université Laval (CRCHUQc-UL), Faculty of Pharmacy, and Centre de Recherche sur le Cancer de l'Université Laval (CRC-UL), Université Laval, Québec, QC G1V 4G2, Canada.
Nguyen Van Long F; Centre Hospitalier Universitaire de Québec Research Center-Université Laval (CRCHUQc-UL), Faculty of Pharmacy, and Centre de Recherche sur le Cancer de l'Université Laval (CRC-UL), Université Laval, Québec, QC G1V 4G2, Canada.
Laverdière I; Centre Hospitalier Universitaire de Québec Research Center-Université Laval (CRCHUQc-UL), Faculty of Pharmacy, and Centre de Recherche sur le Cancer de l'Université Laval (CRC-UL), Université Laval, Québec, QC G1V 4G2, Canada.
Lévesque É; CRCHUQc-UL, Faculty of Medicine, and CRC-UL, Université Laval, Québec, QC G1V 4G2, Canada.
Banerji V; Department of Internal Medicine & Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P4, Canada.; CancerCare Manitoba Research Institute, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada.
Vanura K; Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, 1090 Vienna, Austria.
Guillemette C; Centre Hospitalier Universitaire de Québec Research Center-Université Laval (CRCHUQc-UL), Faculty of Pharmacy, and Centre de Recherche sur le Cancer de l'Université Laval (CRC-UL), Université Laval, Québec, QC G1V 4G2, Canada.; Pokaż więcej
Źródło:: Cells [Cells] 2023 May 02; Vol. 12 (9). Date of Electronic Publication: 2023 May 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell*/metabolism
Humans ; Protein-Tyrosine Kinases/metabolism ; Receptors, Antigen, B-Cell/metabolism ; Signal Transduction ; Phosphorylation ; Glucuronosyltransferase/genetics ; Glucuronosyltransferase/metabolism ; Minor Histocompatibility Antigens/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Early Cytomegalovirus Reactivation in Renal Recipients Is Associated with High Levels of B Cell Maturation Antigen Transcript Expression Prior to Transplantation.
Autorzy:: Alfaro R; Immunology Service, Hospital Clinico Universitario Virgen de la Arrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.
Rodríguez-Aguilar L; Immunology Service, Hospital Clinico Universitario Virgen de la Arrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.
Llorente S; Nephrology Services, Hospital Clinico Universitario Virgen de la Arrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.
Jimenez-Coll V; Immunology Service, Hospital Clinico Universitario Virgen de la Arrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.
Martínez-Banaclocha H; Immunology Service, Hospital Clinico Universitario Virgen de la Arrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.
Galián JA; Immunology Service, Hospital Clinico Universitario Virgen de la Arrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.
Botella C; Immunology Service, Hospital Clinico Universitario Virgen de la Arrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.
Moya-Quiles MR; Immunology Service, Hospital Clinico Universitario Virgen de la Arrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.
Muro-Perez M; Immunology Service, Hospital Clinico Universitario Virgen de la Arrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.
Minguela A; Immunology Service, Hospital Clinico Universitario Virgen de la Arrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.
Legaz I; Department of Legal and Forensic Medicine, Biomedical Research Institute of Murcia (IMIB), Regional Campus of International Excellence 'Campus Mare Nostrum', Faculty of Medicine, University of Murcia, 30100 Murcia, Spain.
Muro M; Immunology Service, Hospital Clinico Universitario Virgen de la Arrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jun 22; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 22.
Typ publikacji:: Journal Article
MeSH Terms:: B-Cell Maturation Antigen*/genetics
B-Cell Maturation Antigen*/metabolism
Cytomegalovirus*
Humans ; Prospective Studies ; Viremia ; Transmembrane Activator and CAML Interactor Protein/genetics ; B-Cell Activating Factor/genetics ; Immunoglobulin G

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell Lymphoma.
Autorzy:: Mohammadnezhad L; Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), AOUP Paolo Giaccone, 90127 Palermo, Italy.; Department of Sciences for Health Promotion and Mother-Child Care 'G. D'Alessandro', University of Palermo, 90127 Palermo, Italy.
Shekarkar Azgomi M; Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), AOUP Paolo Giaccone, 90127 Palermo, Italy.; Department of Biomedicine, Neuroscience and Advanced Diagnosis (BIND), University of Palermo, 90127 Palermo, Italy.
La Manna MP; Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), AOUP Paolo Giaccone, 90127 Palermo, Italy.; Department of Biomedicine, Neuroscience and Advanced Diagnosis (BIND), University of Palermo, 90127 Palermo, Italy.
Guggino G; Department of Sciences for Health Promotion and Mother-Child Care 'G. D'Alessandro', University of Palermo, 90127 Palermo, Italy.
Botta C; Department of Sciences for Health Promotion and Mother-Child Care 'G. D'Alessandro', University of Palermo, 90127 Palermo, Italy.
Dieli F; Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), AOUP Paolo Giaccone, 90127 Palermo, Italy.; Department of Biomedicine, Neuroscience and Advanced Diagnosis (BIND), University of Palermo, 90127 Palermo, Italy.
Caccamo N; Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), AOUP Paolo Giaccone, 90127 Palermo, Italy.; Department of Biomedicine, Neuroscience and Advanced Diagnosis (BIND), University of Palermo, 90127 Palermo, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 May 07; Vol. 24 (9). Date of Electronic Publication: 2023 May 07.
Typ publikacji:: Journal Article
MeSH Terms:: Sjogren's Syndrome*/genetics
Lymphoma, Large B-Cell, Diffuse*/genetics
Lymphoma, Large B-Cell, Diffuse*/pathology
Lymphoma, Non-Hodgkin*
Humans ; Signal Transduction ; Receptors, Antigen, B-Cell/genetics ; Guanine Nucleotide Exchange Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: The exploration of B cell maturation antigen expression in plasma cell dyscrasias beyond multiple myeloma.
Autorzy:: Xu Y; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China.
Mao X; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, 430030, Hubei, China.
Que Y; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China.
Xu M; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China.
Li C; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China.
Almeida VDF; Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
Wang D; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China. .; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, 430030, Hubei, China. .
Li C; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China. .; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, 430030, Hubei, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Feb 07; Vol. 23 (1), pp. 123. Date of Electronic Publication: 2023 Feb 07.
Typ publikacji:: Journal Article
MeSH Terms:: Multiple Myeloma*/drug therapy
Paraproteinemias*
Lymphoma, B-Cell*
Humans ; B-Cell Maturation Antigen/analysis ; B-Cell Maturation Antigen/metabolism ; Immunotherapy ; Immunotherapy, Adoptive

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms.
Autorzy:: Mouhssine S; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, Italy.
Maher N; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, Italy.
Matti BF; Department of Hematology and Bone Marrow Transplant, Hematology and Bone Marrow Transplant Center, Medical City, Baghdad 00964, Iraq.
Alwan AF; Department of Hematology and Bone Marrow Transplant, Hematology and Bone Marrow Transplant Center, Medical City, Baghdad 00964, Iraq.; Department of Clinical Hematology, The National Center of Hematology, Mustansiriyah University, Baghdad 10015, Iraq.
Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 12; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell*/genetics
Leukemia, Lymphocytic, Chronic, B-Cell*/pathology
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Humans ; Adult ; Agammaglobulinaemia Tyrosine Kinase ; Ligands ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa.
Autorzy:: Vest SD; Department of Pathology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.; Department of Ophthalmology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
Eriksen PRG; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
de Groot FA; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
de Groen RAL; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Kleij AHR; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Kirkegaard MK; Department of Pathology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
Kamper P; Department of Hematology, Aarhus University Hospital, 8200 Aarhus, Denmark.
Rasmussen PK; Department of Ophthalmology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
von Buchwald C; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
de Nully Brown P; Department of Hematology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
Kiilgaard JF; Department of Ophthalmology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
Vermaat JSP; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Heegaard S; Department of Pathology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.; Department of Ophthalmology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 07; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: DNA Copy Number Variations*
Lymphoma, Large B-Cell, Diffuse*/genetics
Lymphoma, Large B-Cell, Diffuse*/pathology
Humans ; Retrospective Studies ; Genetic Profile ; Adaptor Proteins, Signal Transducing/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
Autorzy:: Shi S; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241000, China.
Li W; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241000, China.
Ni G; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241000, China.
Ding J; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241000, China.
Liu Y; Department of Pathology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China.
Wu H; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241000, China.
Zhang Z; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241000, China.
Ding Z; Department of Radiology, The First Affiliated Hospital of Wannan Medical College, No. 2 Zheshan West Road, Wuhu, 241000, China. .; Pokaż więcej
Źródło:: BMC women's health [BMC Womens Health] 2024 Apr 18; Vol. 24 (1), pp. 247. Date of Electronic Publication: 2024 Apr 18.
Typ publikacji:: Journal Article
MeSH Terms:: Genital Neoplasms, Female*/diagnosis
Genital Neoplasms, Female*/pathology
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/pathology
Female ; Humans ; Genitalia, Female ; Gynecologic Surgical Procedures ; Neoplasm Staging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
Autorzy:: Zhang LF; Department of Pathology, Fudan University Shanghai Cancer Center, Dong-an Road 270, Xuhui District, Shanghai, CN, 200032, China.
Zhang Y; Department of Pathology, Fudan University Shanghai Cancer Center, Dong-an Road 270, Xuhui District, Shanghai, CN, 200032, China.; Shanghai Medical College, Department of Oncology, Fudan University, Shanghai, CN, 200032, China.
Shui RH; Department of Pathology, Fudan University Shanghai Cancer Center, Dong-an Road 270, Xuhui District, Shanghai, CN, 200032, China.; Shanghai Medical College, Department of Oncology, Fudan University, Shanghai, CN, 200032, China.
Lu HF; Department of Pathology, Fudan University Shanghai Cancer Center, Dong-an Road 270, Xuhui District, Shanghai, CN, 200032, China.; Shanghai Medical College, Department of Oncology, Fudan University, Shanghai, CN, 200032, China.
Jiang WH; Department of Pathology, Fudan University Shanghai Cancer Center, Dong-an Road 270, Xuhui District, Shanghai, CN, 200032, China.
Cai X; Department of Pathology, Fudan University Shanghai Cancer Center, Dong-an Road 270, Xuhui District, Shanghai, CN, 200032, China.
Li XQ; Department of Pathology, Fudan University Shanghai Cancer Center, Dong-an Road 270, Xuhui District, Shanghai, CN, 200032, China.; Shanghai Medical College, Department of Oncology, Fudan University, Shanghai, CN, 200032, China.
Yu BH; Department of Pathology, Fudan University Shanghai Cancer Center, Dong-an Road 270, Xuhui District, Shanghai, CN, 200032, China. .; Shanghai Medical College, Department of Oncology, Fudan University, Shanghai, CN, 200032, China. .; Pokaż więcej
Źródło:: Diagnostic pathology [Diagn Pathol] 2024 Apr 16; Vol. 19 (1), pp. 60. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis
Lymphoma, Follicular*/pathology
Lymphoma, B-Cell, Marginal Zone*/metabolism
Humans ; Adult ; Diagnosis, Differential ; Proto-Oncogene Proteins c-bcl-2 ; Transcription Factors/metabolism ; Antigens, Differentiation, Myelomonocytic/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Eukaryotic initiation factor 3a promotes the development of diffuse large B-cell lymphoma through regulating cell proliferation.
Autorzy:: Sun H; Department of Hematology, Shandong Provincial Hospital, Shandong University, 250021, Jinan, Shandong, China.; Department of Hematology, Binzhou Medical University Hospital, 256603, Binzhou, Shandong, China.
Shang J; Department of Hematology, Shandong Provincial Hospital, Shandong University, 250021, Jinan, Shandong, China.
Liu X; Department of Hematology, Binzhou Medical University Hospital, 256603, Binzhou, Shandong, China.
Ren S; Department of Oncology, Zibo Central Hospital, 255016, Zibo, Shandong, China.
Hu S; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324, Jingwu Road, 250021, Jinan, Shandong, China. .
Wang X; Department of Hematology, Shandong Provincial Hospital, Shandong University, 250021, Jinan, Shandong, China. .; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324, Jingwu Road, 250021, Jinan, Shandong, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 08; Vol. 24 (1), pp. 432. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents*/therapeutic use
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/genetics
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Humans ; Leukocytes, Mononuclear ; Cell Proliferation/genetics ; Peptide Initiation Factors/pharmacology ; Peptide Initiation Factors/therapeutic use ; Cell Line, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma.
Autorzy:: Cho SF; Division of Hematology & Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.; Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.; Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.; Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
Yeh TJ; Division of Hematology & Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.; Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
Wang HC; Division of Hematology & Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
Du JS; Division of Hematology & Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
Gau YC; Division of Hematology & Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
Lin YY; Health Management Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
Chuang TM; Division of Hematology & Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
Liu YC; Division of Hematology & Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
Hsiao HH; Division of Hematology & Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
Moi SH; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 807, Taiwan. .; Research Center for Precision Environmental Medicine, Kaohsiung Medical University, Kaohsiung, 807, Taiwan. .; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 807, Taiwan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 14; Vol. 14 (1), pp. 6161. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article
MeSH Terms:: Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/genetics
Humans ; Prognosis ; Retrospective Studies ; Mutation ; DNA Damage

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Two lymphoma histotypes and papillary thyroid carcinoma coexisting on Hashimoto ground: a case report and review of the literature.
Autorzy:: Iskra I; Clinical Department of Nuclear Medicine, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
Tomaš MI; Clinical Department of Nuclear Medicine, Clinical Hospital Centre Rijeka, Rijeka, Croatia.; Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Crnčić TB; Clinical Department of Nuclear Medicine, Clinical Hospital Centre Rijeka, Rijeka, Croatia. .; Faculty of Medicine, University of Rijeka, Rijeka, Croatia. .
Kukić E; Clinical Department of Nuclear Medicine, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
Hadžisejdić I; Clinical Department of Pathology and Cytology, Clinical Hospital Center Rijeka, Rijeka, Croatia.; Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Avirović M; Clinical Department of Pathology and Cytology, Clinical Hospital Center Rijeka, Rijeka, Croatia.; Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Girotto N; Clinical Department of Nuclear Medicine, Clinical Hospital Centre Rijeka, Rijeka, Croatia.; Faculty of Medicine, University of Rijeka, Rijeka, Croatia.; Pokaż więcej
Źródło:: Diagnostic pathology [Diagn Pathol] 2024 Mar 09; Vol. 19 (1), pp. 52. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:: Review; Case Reports; Journal Article
MeSH Terms:: Carcinoma, Papillary*/pathology
Hashimoto Disease*/pathology
Lymphoma, B-Cell, Marginal Zone*/complications
Lymphoma, B-Cell, Marginal Zone*/pathology
Thyroid Neoplasms*/pathology
Humans ; Male ; Middle Aged ; Thyroid Cancer, Papillary

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Reduced-dose chemotherapy followed by blinatumomab in induction therapy for newly diagnosed B-cell acute lymphoblastic leukemia.
Autorzy:: Lu J; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.
Zhou H; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.
Zhou X; Department of Hematology, Wuxi People's Hospital Affiliated to Nanjing Medical University, WuXi, China.
Yang Y; Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Tong L; Yixing People's Hospital, The Affiliated Hospital of Jiangsu University, Yixing, China.
Miao M; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.
Yang X; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.
Chen S; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7062.
Typ publikacji:: Journal Article
MeSH Terms:: Antibodies, Bispecific*/adverse effects
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Burkitt Lymphoma*/drug therapy
Humans ; Retrospective Studies ; Induction Chemotherapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Importance of Rare Gene Alterations in the Prognosis of B-Cell Acute Lymphoblastic Leukemia
Autorzy:: Xiang L; Zhejiang Provincial People’s Hospital Bijie Hospital, Department of Science and Education, Bijie, China
Wang Y; Xinchang Hospital Affiliated to Wenzhou Medical University, Department of Thoracic Surgery, Xinchang, China
Pan W; Haiyan People’s Hospital, Department of Clinical Laboratory, Haiyan, China; Pokaż więcej
Źródło:: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Mar 01; Vol. 41 (1), pp. 49-50. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:: Journal Article
MeSH Terms:: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Burkitt Lymphoma*
Humans ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction
Autorzy:: Erdem S; İstanbul University, İstanbul Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Türkiye
Nalçacı M; İstanbul University, İstanbul Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Türkiye; Pokaż więcej
Źródło:: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Mar 01; Vol. 41 (1), pp. 55-56. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Lymphocytic, Chronic, B-Cell*/complications
Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy
Anemia*
Thrombocytopenia*/chemically induced
Thrombocytopenia*/diagnosis
Thrombocytopenia*/drug therapy
Adenine/*analogs & derivatives
Humans ; Piperidines/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Activation-induced cytidine deaminase causes recurrent splicing mutations in diffuse large B-cell lymphoma.
Autorzy:: Benitez-Cantos MS; GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS Granada - Avenida de la Ilustración 114, Granada, 18016, Spain.; Health Research Institute of Granada (Ibs.Granada), Avenida de Madrid 15, Granada, 18012, Spain.; Department of Biochemistry and Molecular Biology III and Immunology, Faculty of Medicine, University of Granada, Avenida de la Investigación 11, Granada, 18016, Spain.
Cano C; Department of Computer Science and Artificial Intelligence, School of Computer and Telecommunication Engineering, University of Granada, Calle Periodista Daniel Saucedo Aranda s/n, Granada, 18014, Spain.
Cuadros M; GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS Granada - Avenida de la Ilustración 114, Granada, 18016, Spain.; Health Research Institute of Granada (Ibs.Granada), Avenida de Madrid 15, Granada, 18012, Spain.; Department of Biochemistry and Molecular Biology III and Immunology, Faculty of Medicine, University of Granada, Avenida de la Investigación 11, Granada, 18016, Spain.
Medina PP; GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS Granada - Avenida de la Ilustración 114, Granada, 18016, Spain. .; Health Research Institute of Granada (Ibs.Granada), Avenida de Madrid 15, Granada, 18012, Spain. .; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Avenida de Fuentenueva s/n, Granada, 18071, Spain. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2024 Feb 24; Vol. 23 (1), pp. 42. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Lymphoma, Large B-Cell, Diffuse*/genetics
Lymphoma, Large B-Cell, Diffuse*/pathology
Humans ; Animals ; Mice ; Mutation ; Cytidine Deaminase/genetics

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Systematic evaluation of B-cell clonal family inference approaches.
Autorzy:: Balashova D; Amsterdam UMC location University of Amsterdam, Epidemiology and Data Science, Meibergdreef 9, Amsterdam, Netherlands.; Amsterdam Public Health, Methodology, Amsterdam, The Netherlands.; Amsterdam Infection and Immunity, Inflammatory Diseases, Amsterdam, The Netherlands.
van Schaik BDC; Amsterdam UMC location University of Amsterdam, Epidemiology and Data Science, Meibergdreef 9, Amsterdam, Netherlands.; Amsterdam Public Health, Methodology, Amsterdam, The Netherlands.; Amsterdam Infection and Immunity, Inflammatory Diseases, Amsterdam, The Netherlands.
Stratigopoulou M; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC location University of Amsterdam, Medical Microbiology and Infection Prevention, Meibergdreef 9, Amsterdam, Netherlands.
Guikema JEJ; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC location University of Amsterdam, Pathology, Lymphoma and Myeloma Center Amsterdam, Meibergdreef 9, Amsterdam, Netherlands.
Caniels TG; Amsterdam UMC location University of Amsterdam, Medical Microbiology and Infection Prevention, Meibergdreef 9, Amsterdam, Netherlands.; Amsterdam Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Claireaux M; Amsterdam UMC location University of Amsterdam, Medical Microbiology and Infection Prevention, Meibergdreef 9, Amsterdam, Netherlands.; Amsterdam Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
van Gils MJ; Amsterdam UMC location University of Amsterdam, Medical Microbiology and Infection Prevention, Meibergdreef 9, Amsterdam, Netherlands.; Amsterdam Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Musters A; Amsterdam UMC location University of Amsterdam, Experimental Immunology, Meibergdreef 9, Amsterdam, Netherlands.; Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands.
Anang DC; Amsterdam UMC location University of Amsterdam, Experimental Immunology, Meibergdreef 9, Amsterdam, Netherlands.; Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands.
de Vries N; Amsterdam UMC location University of Amsterdam, Experimental Immunology, Meibergdreef 9, Amsterdam, Netherlands.; Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands.
Greiff V; Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.
van Kampen AHC; Amsterdam UMC location University of Amsterdam, Epidemiology and Data Science, Meibergdreef 9, Amsterdam, Netherlands. .; Amsterdam Public Health, Methodology, Amsterdam, The Netherlands. .; Amsterdam Infection and Immunity, Inflammatory Diseases, Amsterdam, The Netherlands. .; Biosystems Data Analysis, Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands. .; Pokaż więcej
Źródło:: BMC immunology [BMC Immunol] 2024 Feb 08; Vol. 25 (1), pp. 13. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: B-Lymphocytes*
Receptors, Antigen, B-Cell*/genetics
Humans ; Mutation ; High-Throughput Nucleotide Sequencing

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88 diffuse large B-cell lymphoma.
Autorzy:: Deng T; Department of Hematology, Chongqing Fifth People's Hospital, Chongqing, PR China.
Zhang S; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Xiao M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Gu J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Huang L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Zhou X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e7005.
Typ publikacji:: Journal Article
MeSH Terms:: Myeloid Differentiation Factor 88*/genetics
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/genetics
Lymphoma, Large B-Cell, Diffuse*/pathology
Piperidines*
Pyridines*
Humans ; Aged ; Rituximab/therapeutic use ; Disease-Free Survival ; Retrospective Studies ; Vincristine/adverse effects ; Cyclophosphamide/adverse effects ; Doxorubicin/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Prednisone/adverse effects ; CD79 Antigens/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: The impact of Epstein-Barr virus latent membrane protein 2A on the production of B cell activating factor of the tumor necrosis factor family (BAFF), APRIL and their receptors.
Autorzy:: Madayag K; Department of Biomedical Sciences, College of Graduate Studies, Downers Grove, Illinois, USA.
Incrocci R; Department of Microbiology and Immunology, College of Graduate Studies, Midwestern University, Downers Grove, Illinois, USA.
Swanson-Mungerson M; Department of Microbiology and Immunology, College of Graduate Studies, Midwestern University, Downers Grove, Illinois, USA.; Pokaż więcej
Źródło:: Immunity, inflammation and disease [Immun Inflamm Dis] 2022 Nov; Vol. 10 (11), pp. e729.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Epstein-Barr Virus Infections*
Lymphoma, B-Cell*
Humans ; B-Cell Activating Factor ; Herpesvirus 4, Human/metabolism ; B-Cell Maturation Antigen ; Transmembrane Activator and CAML Interactor Protein ; Tumor Necrosis Factor-alpha ; Interleukin-4

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: RAC1 , a Potential Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma.
Autorzy:: Wu X; Department of Hematology, The Affiliated Zhongda Hospital, Institute of Hematology, Southeast University, Nanjing 210009, China.
Li Y; Department of Oncology, School of Medicine, Southeast University, Nanjing 210009, China.
Zhang W; Department of Cellular & Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON K1A 0R6, Canada.
Zhang J; Department of Hematology, The Affiliated Zhongda Hospital, Institute of Hematology, Southeast University, Nanjing 210009, China.
Chen B; Department of Hematology, The Affiliated Zhongda Hospital, Institute of Hematology, Southeast University, Nanjing 210009, China.
Ge Z; Department of Hematology, The Affiliated Zhongda Hospital, Institute of Hematology, Southeast University, Nanjing 210009, China.; Pokaż więcej
Źródło:: Cells [Cells] 2022 Dec 14; Vol. 11 (24). Date of Electronic Publication: 2022 Dec 14.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/genetics
Lymphoma, Large B-Cell, Diffuse*/pathology
Humans ; Prognosis ; Receptors, Antigen, B-Cell/metabolism ; rac1 GTP-Binding Protein/genetics ; rac1 GTP-Binding Protein/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""B-Cell"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji